Infeur Adulti (Fosfomycin Trometamol)

Fosfomycin trometamol acts by inhibiting the bacterial enzyme MurA, which is essential for the first step of peptidoglycan synthesis. By blocking this pathway, the drug prevents formation of the bacterial cell wall, leading to cell lysis and eradication of susceptible organisms.

The dosage of Infeur Adulti is determined by the prescribing clinician based on the patient’s condition, renal function, and local treatment guidelines. The prescriber will specify the exact amount and timing appropriate for each individual case.

Safety data for fosfomycin trometamol in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and after a careful risk‑benefit assessment by the healthcare provider.

To request Infeur Adulti, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with nitrofurantoin or trimethoprim‑sulfamethoxazole, fosfomycin offers a single‑dose regimen, which can improve adherence. It retains activity against many multidrug‑resistant strains, though local susceptibility patterns should guide selection. Each agent has a distinct safety profile, so clinicians consider patient factors when choosing therapy.

Infeur Adulti should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keeping the product in a dry, well‑ventilated area helps maintain its stability and potency throughout its shelf life.

Infeur Adulti is taken orally as a single tablet, usually with a full glass of water. It is generally administered on an empty stomach, at least two hours before or after meals, unless the prescribing information advises otherwise.

The most serious risks include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and rare hepatic dysfunction. Patients should be instructed to seek immediate medical attention if they develop rash, difficulty breathing, persistent diarrhea, or signs of liver injury.

Infeur Adulti is contraindicated in individuals with a known hypersensitivity to fosfomycin or any component of the formulation. Caution is also advised for patients with severe renal impairment, pregnant women where benefits do not outweigh risks, and those taking medications that may cause major drug interactions.